Ligand Pharmaceuticals, Inc. (LGND)
196.70
+3.73
(+1.93%)
USD |
NASDAQ |
Jan 20, 16:00
196.70
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals EPS Diluted (Quarterly): 5.685 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Johnson & Johnson | 2.121 |
| Elanco Animal Health, Inc. | -0.0684 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Krystal Biotech, Inc. | 2.660 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 117.27M |
| Revenue (Quarterly) | 115.46M |
| Total Expenses (Quarterly) | -1.812M |
| Enterprise Value | 3.584B |
| Gross Profit Margin (Quarterly) | 89.70% |
| Earnings Yield | 1.06% |
| Operating Earnings Yield | 0.75% |
| Normalized Earnings Yield | 0.1147 |